Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
50-70-4
Name of the chemical
D-glucitol C6H14O6
Concentration
N/A
EC/CAS
9005-64-5
Name of the chemical
polyethyleneglycol sorbitan monolaurate
Concentration
N/A
General Information
Version
1.0
Revision date
2022-07-29
Product name
STIMUFEND (pegfilgrastim-fpgk) injection, for subcutaneous use
Product Synonyms
Pegfilgrastim 6 mg/0.6 mL
Emergency telephone
(800)255-3924, +1 (813)248-0585
Icons in SDS
Company Information
company name
Co-Manufacturer
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Classification of the Substance or Mixture GHS-US/CA Classification Reproductive toxicity Category 2 H361
2.2 Label elements
GHS-US/CA Labeling
Hazard pictograms
GHS08
Signal word
Warning
Hazard statements
H361 - Suspected of damaging fertility or the unborn child.
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing, and eye protection. P308+P313 - If exposed or concerned: Get medical advice/attention. P405 - Store locked up. P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations.
Other hazards
Exposure may aggravate pre-existing eye, skin, or respiratory conditions.
Ingredient(s) with unknown acute toxicity
No additional information available
2.1 Classification of the substance or mixture
GHS-US/CA Classification Reproductive toxicity Category 2 H361